Literature DB >> 1894946

Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.

S Iacobelli, C Natoli, M D'Egidio, E Tamburrini, A Antinori, L Ortona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1894946     DOI： 10.1093/infdis/164.4.819

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.

Authors:  B Gröschel; J J Braner; M Funk; R Linde; H W Doerr; J Cinatl; S Iacobelli
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Differentiating children with sepsis with and without acute respiratory distress syndrome using proteomics.

Authors:  Nadir Yehya; Hossein Fazelinia; Deanne M Taylor; Gladys G Lawrence; Lynn A Spruce; Jill M Thompson; Susan S Margulies; Steven H Seeholzer; G Scott Worthen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-05       Impact factor: 5.464

Review 3.  Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Valentina Gallo; Alyexandra Arienzo; Stefano Iacobelli; Valentina Iacobelli; Giovanni Antonini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.

Authors:  Veronika Lodermeyer; Kristina Suhr; Nicola Schrott; Christian Kolbe; Christina M Stürzel; Daniela Krnavek; Jan Münch; Christian Dietz; Tanja Waldmann; Frank Kirchhoff; Christine Goffinet
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

Review 5.  A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.

Authors:  Christoffer T Nielsen; Ole Østergaard; Niclas S Rasmussen; Søren Jacobsen; Niels H H Heegaard
Journal:  Clin Proteomics       Date:  2017-04-08       Impact factor: 3.988

6.  Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.

Authors:  Chang-Soo Hong; Mi-Ra Park; Eun-Gene Sun; Wonyoung Choi; Jun-Eul Hwang; Woo-Kyun Bae; Joon Haeng Rhee; Sang-Hee Cho; Ik-Joo Chung
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

7.  Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.

Authors:  Ana Mendes-Frias; Valentina Gallo; Valentina Iacobelli; Roberta Gentile; Giovanni Antonini; Ricardo Silvestre; Stefano Iacobelli
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

8.  M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.

Authors:  Qin Wang; Xiaolin Zhang; Yuling Han; Xinlu Wang; Guangxia Gao
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 9.  Severity Biomarkers in Puumala Hantavirus Infection.

Authors:  Tuula K Outinen; Satu Mäkelä; Ilkka Pörsti; Antti Vaheri; Jukka Mustonen
Journal:  Viruses       Date:  2021-12-28       Impact factor: 5.048

10.  LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis.

Authors:  Meiyan Luo; Qian Zhang; Yingchun Hu; Changfeng Sun; Yunjian Sheng; Cunliang Deng
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.